OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Advanced
Search
46
Results
Show all
Save search
Copy query
Show results for
Unknown
(46)
Release Date
2018
(30)
2021
(5)
2025
(3)
2026
(2)
2024
(2)
2015
(2)
2022
(1)
2016
(1)
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
Assessing the Effect of Personalized Diabetes Risk Assessments During Ophthalmologic Visits on Glycemic Control: A Randomized Clinical Trial.
Not available
S-EPMC4924347
|
biostudies-literature
Cite
Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition).
Not available
S-EPMC4835977
|
biostudies-literature
Cite
Extracorporeal Life Support Organization Registry International Report 2022: 100,000 Survivors.
Not available
S-EPMC10962646
|
biostudies-literature
Cite
Oral Semaglutide and Heart Failure Outcomes in Persons With Type 2 Diabetes: A Secondary Analysis of the SOUL Randomized Clinical Trial.
Not available
S-EPMC12865694
|
biostudies-literature
Cite
Impact of Oral Semaglutide on Kidney Outcomes in People With Type 2 Diabetes: Results From the SOUL Randomized Trial.
Not available
S-EPMC12824789
|
biostudies-literature
Cite
Pathogenic Germline Variants in 10,389 Adult Cancers.
Not available
S-EPMC5949147
|
biostudies-literature
Cite
Chromosome Xq23 is associated with lower atherogenic lipid concentrations and favorable cardiometabolic indices.
Not available
S-EPMC8042019
|
biostudies-literature
Cite
Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.
Not available
S-EPMC5966039
|
biostudies-literature
Cite
Perspective on Oncogenic Processes at the End of the Beginning of Cancer Genomics.
Not available
S-EPMC5916814
|
biostudies-literature
Cite
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Not available
S-EPMC9422774
|
biostudies-literature
Cite
Previous
page
1 / 5
You're on page
1
page
2
page
3
page
4
page
5
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets